Rio Health has raised $4.5 million in a pre-Series A round led by Version One Ventures to scale its rapid pharmacy delivery network in the Delhi NCR region. The startup plans to expand its dark store footprint and improve technology for demand forecasting and delivery efficiency.
- Raised $4.5M pre-Series A led by Version One Ventures
- Plans 12 more dark stores in Delhi NCR to speed up deliveries
- Targets ₹150 Cr ARR in next 9-12 months
What happened
Rio Health, a quick commerce startup focused on pharmacy and healthcare essentials, announced a $4.5 million pre-Series A funding round led by Version One Ventures along with participation from existing investors. The fresh capital brings the startup's total funding to about $6.5 million and will be used primarily to expand its delivery network across Delhi NCR by opening 12 additional dark stores.
Founded by Ankur Agrawal and Amit Ahuja, Rio Health leverages AI technology to enable customers to order medicines within 20-30 minutes by typing, speaking, or uploading prescriptions. Its system automatically processes orders verified by licensed pharmacists and currently handles over 30,000 orders each month, serving more than 20,000 SKUs with around 80% repeat business coming from loyal customers.
Why it matters
The quick commerce sector in India is rapidly growing, with expectations of reaching $30 to $40 billion in market size within a few years. Rio Health’s focus on the regulated pharma segment highlights the increasing demand for specialized delivery services that address the complexities of medicine sales, including prescription verification and controlled inventory management.
Moreover, the competitive landscape includes large quick commerce players pushing into pharmacy delivery, but the sector's regulatory and operational challenges have created opportunities for niche startups like Rio Health. Their ability to forecast neighborhood-level demand and use AI for efficient stocking positions them well to capture a significant share of this evolving market.
What to watch next
Rio Health's progress in scaling its dark stores and further developing its technology will be critical to meeting its target of surpassing ₹150 crore in annual recurring revenue within the next year. Observers should track how efficiently the startup integrates new locations and improves delivery speed and accuracy amid growing competition.
Additionally, monitoring regulatory developments affecting quick commerce pharmacy delivery in India will be important. Rapid growth in this space may invite closer scrutiny or new guidelines, and how Rio Health navigates these changes alongside competitors like Zepto and Swiggy Instamart exploring medicine deliveries will shape the future landscape.